Empagliflozin - Boehringer Ingelheim/Eli Lilly and Company
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Cipla; Eli Lilly and Company; Lupin
- Drug Class Antihyperglycaemics; Benzhydryl compounds; Cardiovascular therapies; Chlorinated hydrocarbons; Cyclic ethers; Glucosides; Heart failure therapies; Small molecules; Urologics
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 14
- NDAs 1
- International Patents 323
- Patent Applications 698
Table of Contents
Disclaimer